Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal peptidase complex subunit 2 (SPCS2) is a protein-coding gene that encodes a component of the signal peptidase complex (SPC) located in the membrane of the endoplasmic reticulum[1][5][8]. The SPC catalyzes cleavage of N-terminal signal sequences from nascent proteins during their translocation into the endoplasmic reticulum lumen, a critical step in the maturation and secretion of many proteins[2][3][4]. SPCS2 enhances and facilitates the enzyme activity of the complex, and is conserved across species. Mutations or dysregulation may be involved in diseases such as spinocerebellar ataxia 13 and have roles in infectious disease-related pathways[1][5]. No drugs are currently reported to directly interact with or target SPCS2, and there are no established clinical biomarkers or safety issues specifically tied to this entity.
None reported specifically for drugs targeting SPCS2. General mechanism is proteolytic cleavage of signal peptides during protein biosynthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptidase complex subunit 2 (SPCS2).